AC Immune holds extraordinary general meeting
ACIU•AC Immune held an extraordinary general meeting on Oct. 2, 2026, where shareholders backed Tom Graney’s appointment to the board through the close of the 2027 annual general meeting.
1. Board appointment approved
Shareholders backed Tom Graney’s appointment to AC Immune’s board through the close of the 2027 annual general meeting at the extraordinary general meeting held Oct. 2, 2026.
